|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
5771252 |
| 003 |
ICU |
| 005 |
20060809175400.0 |
| 008 |
041206s2005 ilua b 001 0 eng |
| 010 |
|
|
|a 2004029045
|
| 020 |
|
|
|a 0810122278 (pbk. : alk. paper)
|
| 040 |
|
|
|a DNLM/DLC
|c DLC
|d DLC
|d UtOrBLW
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a TP248.2
|b .K45 2005
|
| 060 |
1 |
0 |
|a W 82
|b K29 2005
|
| 082 |
0 |
0 |
|a 660.6
|2 22
|
| 245 |
0 |
0 |
|a Kellogg on biotechnology :
|b thriving through integration /
|c edited by Alicia Löffler.
|
| 260 |
|
|
|a Evanston, Ill. :
|b Northwestern University Press :
|b Kellogg School of Management ;
|a London :
|b Kogan Page,
|c c2005.
|
| 300 |
|
|
|a xiii, 264 p. :
|b ill. ;
|c 23 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|t Preface /
|r Alicia Loffler --
|g Pt. I.
|t Emerging technologies : the fuel of biotechnology --
|g 1.
|t Promises and challenges of the U.S. stem cell industry /
|r Whit Alexander and Shail Thaker --
|g 2.
|t Pharmacogenomics : overcoming the hurdles to adoption /
|r Janette Chung, Peggy Mathias and Rebecca Wildman --
|g 3.
|t Nanobiotechnology : applications and commercialization strategies /
|r Badri Amurthur, Barry Grant, Markus Hildinger, Eric Hyllengren, Mohammed Ladha, Michael Masters, Daniel Shuffrin and Jing Ye --
|g Pt. II.
|t The business of science : enhancing the value of the innovations through the perfect business model --
|g 4.
|t Sustaining platforms /
|r Erich Hoefer, Sriram Jambunathan, Anne Tse and Mariona Vincens --
|g 5.
|t Mergers and acquisitions as a strategic alternative in biotech /
|r Andrew Ingley, Gregory Lief and Jeanne Lukacek --
|g Pt. III.
|t The home stretch : commercializing and capturing the value of the innovation --
|g 6.
|t Biologics manufacturing : the make or buy decision /
|r Anurag Bagaria --
|g 7.
|t Pharming factories /
|r Andrew Ingley, James Pavlik and Ty Smith --
|g 8.
|t The role of marketing /
|r Dario Benavides, Lanier Coles, Gary Dulaney, Vanessa Rath and Carla Yarger --
|g 9.
|t To DTC or not to DTC : direct-to-consumer marketing in medical devices /
|r Roy Katz, Edna Lazar, Christopher Pfaff and Thomas Walsh --
|g 10.
|t The forgotten issue : reimbursement in biotechnology /
|r Raj Changrani, William Gangi, Alice Manard, Seung Sohn and Steven Stark.
|
| 650 |
|
0 |
|a Biotechnology.
|0 http://id.loc.gov/authorities/subjects/sh00007765
|
| 650 |
|
0 |
|a Biotechnology industries.
|0 http://id.loc.gov/authorities/subjects/sh85014264
|
| 650 |
1 |
2 |
|a Biomedical Technology.
|
| 650 |
2 |
2 |
|a Biotechnology
|x economics.
|
| 650 |
2 |
2 |
|a Biotechnology
|x organization & administration.
|
| 650 |
2 |
2 |
|a Technology, Pharmaceutical.
|
| 650 |
|
7 |
|a Biotechnology.
|2 fast
|0 http://id.worldcat.org/fast/fst00832729
|
| 650 |
|
7 |
|a Biotechnology industries.
|2 fast
|0 http://id.worldcat.org/fast/fst00832791
|
| 700 |
1 |
|
|a Löffler, Alicia.
|0 http://id.loc.gov/authorities/names/n2004124549
|1 http://viaf.org/viaf/78178846
|
| 710 |
2 |
|
|a Kellogg Center for Biotechnology.
|0 http://id.loc.gov/authorities/names/n2004124550
|1 http://viaf.org/viaf/144455662
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 903 |
|
|
|a Hathi
|
| 035 |
|
|
|a (OCoLC)57202443
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i c44ed93e-9016-5f59-a125-88c5c9a9efb9
|s bad13e44-a7d3-5dbb-9ca5-12da1a8a3b4f
|
| 928 |
|
|
|t Library of Congress classification
|a TP248.2 .K45 2005
|l JRL
|c JRL-Gen
|i 5022574
|
| 927 |
|
|
|t Library of Congress classification
|a TP248.2 .K45 2005
|l JRL
|c JRL-Gen
|e CHBO
|b 70973672
|i 7924256
|
